Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement.

Abstract excerpt

Engaging patients as partners in biomedical research has gradually gained consensus over the last two decades. They provide a different perspective on health priorities and help to improve design and outcomes of clinical studies. This paper describes the relationship established between scientists and members of a large family at genetic risk of very rare lethal disease, fatal familial insomnia (FFI). This...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mutation
• Share to Prion Diseases